156 related articles for article (PubMed ID: 32266659)
1. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression.
Guo Z; Jia H; Ge J
Hum Cell; 2020 Jul; 33(3):750-758. PubMed ID: 32277426
[TBL] [Abstract][Full Text] [Related]
3. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6.
Lu J; Zhao Z; Ma Y
Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940
[TBL] [Abstract][Full Text] [Related]
4.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
5. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
6. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
8. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
Han N; Li H; Wang H
Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
[TBL] [Abstract][Full Text] [Related]
10. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6.
Cao J; Zhang Y; Mu J; Yang D; Gu X; Zhang J
Hum Cell; 2021 Jul; 34(4):1185-1196. PubMed ID: 33813728
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
Gu JF; Liu SG; Pan Q; Qin F; Li YY
Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
Jiao D; Wu M; Ji L; Liu F; Liu Y
Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
15. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
Su Y; Zhou L; Yu Q; Lu J; Liu W
Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
[TBL] [Abstract][Full Text] [Related]
17. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
18. MiR-384 represses tumorigenesis by regulating CDK6 and predicts prognosis of clear cell renal cell carcinoma.
Guo L; Wang D; Zhang Z
J BUON; 2018; 23(3):787-794. PubMed ID: 30003753
[TBL] [Abstract][Full Text] [Related]
19. MiR-30a suppresses clear cell renal cell carcinoma proliferation and metastasis by targeting LRP6.
Ren Y; Zhang L; Zhang W; Gao Y
Hum Cell; 2021 Mar; 34(2):598-606. PubMed ID: 33400244
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
